DE69823650D1 - Azasteroidverbindung zur behandlung oder vorbeugung von prostatakrebs - Google Patents

Azasteroidverbindung zur behandlung oder vorbeugung von prostatakrebs

Info

Publication number
DE69823650D1
DE69823650D1 DE69823650T DE69823650T DE69823650D1 DE 69823650 D1 DE69823650 D1 DE 69823650D1 DE 69823650 T DE69823650 T DE 69823650T DE 69823650 T DE69823650 T DE 69823650T DE 69823650 D1 DE69823650 D1 DE 69823650D1
Authority
DE
Germany
Prior art keywords
prostate cancer
treating
preventing prostate
compound
azasteroid compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69823650T
Other languages
English (en)
Other versions
DE69823650T2 (de
Inventor
Koichi Kojima
Tomowo Kobayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Application granted granted Critical
Publication of DE69823650D1 publication Critical patent/DE69823650D1/de
Publication of DE69823650T2 publication Critical patent/DE69823650T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DE69823650T 1997-02-26 1998-02-26 Azasteroidverbindung zur behandlung oder vorbeugung von prostatakrebs Expired - Fee Related DE69823650T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP4233597 1997-02-26
JP4233597 1997-02-26
PCT/JP1998/000767 WO1998038207A1 (fr) 1997-02-26 1998-02-26 Compositions de traitement ou de prevention du cancer de la prostate

Publications (2)

Publication Number Publication Date
DE69823650D1 true DE69823650D1 (de) 2004-06-09
DE69823650T2 DE69823650T2 (de) 2004-12-09

Family

ID=12633151

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69823650T Expired - Fee Related DE69823650T2 (de) 1997-02-26 1998-02-26 Azasteroidverbindung zur behandlung oder vorbeugung von prostatakrebs

Country Status (20)

Country Link
EP (1) EP0963998B1 (de)
KR (1) KR20000075651A (de)
CN (1) CN1131239C (de)
AT (1) ATE265854T1 (de)
AU (1) AU739308B2 (de)
BR (1) BR9807767A (de)
CA (1) CA2282836A1 (de)
DE (1) DE69823650T2 (de)
DK (1) DK0963998T3 (de)
ES (1) ES2221703T3 (de)
HK (1) HK1023576A1 (de)
HU (1) HUP0001441A3 (de)
ID (1) ID22762A (de)
IL (1) IL131380A0 (de)
NO (1) NO994107L (de)
NZ (1) NZ337048A (de)
PL (1) PL335365A1 (de)
PT (1) PT963998E (de)
RU (1) RU2196582C2 (de)
WO (1) WO1998038207A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010022066A (ko) * 1997-07-29 2001-03-15 가와무라 요시부미 탈모증 등 치료제
WO2005099653A1 (en) 2004-04-14 2005-10-27 Eun-Joo Lee Pharmaceutical composition for treating hair loss and benign prostatic hyperplasia
KR100698400B1 (ko) 2004-04-14 2007-03-23 이은주 탈모증 및 전립선비대증 치료를 위한 약제학적 조성물
EP1726650A1 (de) * 2005-05-27 2006-11-29 Universitätsklinikum Freiburg Monoklonale Antikörper und Einzelkettenantikörper Fragments gegen das zelloberflächen Prostataspezifische Membranantigen
RU2695348C2 (ru) * 2018-04-26 2019-07-23 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр радиологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ радиологии" Минздрава России) Способ лечения больных с наличием метастазов в лимфатических узлах и олигометастазов в костях скелета при раке предстательной железы

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8505862D0 (en) * 1985-03-07 1985-04-11 Erba Farmitalia Steroidic 5alpha-reductase inhibitors
IE76452B1 (en) * 1990-10-29 1997-10-22 Sankyo Co Azasteroid compounds for the treatment of prostatic hypertrophy their preparation and use
JPH06293793A (ja) * 1993-02-10 1994-10-21 Sankyo Co Ltd ステロイド−１７−アミド類の製造法
JPH0873492A (ja) * 1994-06-28 1996-03-19 Sankyo Co Ltd アザステロイド類
JPH0819151A (ja) * 1994-06-30 1996-01-19 Furukawa Electric Co Ltd:The アーマロッド巻付構造
NZ326897A (en) * 1996-02-05 1999-08-30 Sankyo Co 5 <alpha>-reductase inhibitory preparation for oral administration, process for producing the same, and use thereof
KR20010022066A (ko) * 1997-07-29 2001-03-15 가와무라 요시부미 탈모증 등 치료제

Also Published As

Publication number Publication date
EP0963998A4 (de) 2002-06-12
PL335365A1 (en) 2000-04-25
EP0963998B1 (de) 2004-05-06
EP0963998A1 (de) 1999-12-15
NO994107D0 (no) 1999-08-25
PT963998E (pt) 2004-07-30
NZ337048A (en) 2000-10-27
HK1023576A1 (en) 2000-09-15
NO994107L (no) 1999-08-25
CN1252805A (zh) 2000-05-10
WO1998038207A1 (fr) 1998-09-03
HUP0001441A3 (en) 2001-03-28
CN1131239C (zh) 2003-12-17
BR9807767A (pt) 2000-02-22
HUP0001441A2 (hu) 2000-10-28
ES2221703T3 (es) 2005-01-01
AU739308B2 (en) 2001-10-11
CA2282836A1 (en) 1998-09-03
DE69823650T2 (de) 2004-12-09
AU6115998A (en) 1998-09-18
ATE265854T1 (de) 2004-05-15
RU2196582C2 (ru) 2003-01-20
IL131380A0 (en) 2001-01-28
ID22762A (id) 1999-12-09
KR20000075651A (ko) 2000-12-26
DK0963998T3 (da) 2004-08-16

Similar Documents

Publication Publication Date Title
NZ332762A (en) Isobutylgaba and its derivatives for the treatment of pain
BR9909961A (pt) Derivados de cadeia lateral alquila e alquenila funcionalizados de glicinamidas como inibidores de farnesil transferase
BR9709427A (pt) Oxa ácidos e compostos relacionados para tratamento de condições da pele
DE69534287D1 (de) Bioabbaubare quaternäre Haarbehandlungsmittel
IL175398A0 (en) Steroidal compounds and pharmaceutical compositions containing them for treating oxidative stress and inflammation
NO306902B1 (no) Anvendelse av indolokarbazolderivater til fremstilling av et medikament for å behandle en patologisk tilstand av prostata
ATE263771T1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
DE69713273D1 (de) Verwendung von 3,4-Diphenylchromanen zur Herstellung eines Arzneimittels zur Behandlung bzw. Vorbeugung des Prostatakarzinoms
ATE180669T1 (de) Verwendung von pregnanderivaten zur behandlung von tumoren
DE69502223D1 (de) Neue Verwendung von 1Alpha-fluor-25-hydroxy-16-en-23-yn-cholecalciferol
DE69823650D1 (de) Azasteroidverbindung zur behandlung oder vorbeugung von prostatakrebs
DE3867652D1 (de) N-substituierte 3,4-dihydropyrimidinverbindungen als mittel zur behandlung von erkrankungen des kardiovaskularen systems.
ATE162045T1 (de) Polyquaternäre ammoniumverbindungen enthaltende antimikrobielle mittel
BR9906803A (pt) Processo para tratamento de copd
ATE262337T1 (de) Azasteroidverbindung zur behandlung von alopezie, hirsutismus und seborrhoe
TR200102205T2 (tr) Anti-konvülsan türevlerinin bulimia nevruza tedavisinde kullanılmaları.
ATE279182T1 (de) Verwendung spezieller verbindungen zur prophylaxe und therapie von hepatitis c
DE3770481D1 (de) Verwendung von imidazochinazolinen zur behandlung und verhinderung von nephritis.
ATE12582T1 (de) Mittel zur krebsbehandlung.
TR199901992T2 (xx) Prostat kanserinin tedavisi ya da önlenmesi için terkip.
MX9702211A (es) Hidroxifenil triazinas.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee